Clinical Trials on Nasal Septum; Deviation, Congenital in Germany

Total 31 results

RWTH Aachen University

Unknown

The Effect of the Hole in the Cardiac Septum Developed by the MitraClip Procedure on the Blood Flow Mechanics (MitraClipASD)

Atrial Septal Defect

Germany
Carag AG

Completed

Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale

Atrial Septal Defect | Patent Foramen Ovale

Germany
atHeart Medical

Active, not recruiting

Post Market Registry of the CBSO (CBSO Registry)

Atrial Septal Defect | Patent Foramen Ovale

Germany
SeptRx, Inc.

Unknown

InterSEPT: In-Tunnel SeptRx European PFO Trial (InterSEPT)

Heart Septal Defects | Heart Defects, Congenital | Foramen Ovale, Patent

Germany, France
Carag AG

Completed

FIH Study With CBSO

Atrial Septal Defect (ASD) | Patent Foramen Ovale (PFO)

Germany
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

Ventricular Septal Defect

Italy, Germany
pfm medical ag
MDT Medical Device Testing GmbH

Completed

Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System (09k003)

Heart Septal Defects, Atrial | Foramen Ovale, Patent | Heart Catheterization

Germany
Heart Center Leipzig - University Hospital

Active, not recruiting

MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure

Mitral Valve Insufficiency | Heart Septal Defects, Atrial

Germany
Occlutech International AB

Active, not recruiting

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Perimembranous Ventricular Septal Defect

Thailand, Germany, Ireland, Vietnam
pfm medical ag
Aix Scientifics

Completed

Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System (pfm-01/2005)

Heart Septal Defects, Ventricular

Germany, Israel
Lifetech Scientific (Shenzhen) Co., Ltd.

Completed

Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder (PFO)

Patent Foramen Ovale

Ireland, Germany
European Cardiovascular Research Center
Comed B.V.

Unknown

Hyperion™ International Registry Trial (COM-01)

Patent Ductus Arteriosus | Atrial Septal Defects

France, Germany, Algeria, China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

CeraFlex PFO Closure System PMCF Study

Patent Foramen Ovale

Germany
Lifetech Scientific (Shenzhen) Co., Ltd.
Medtronic

Completed

Lifetech CeraFlex™ Post-Market Surveillance Study

Atrial Septal Defect | Patent Foramen Ovale | Patent Ductus Arteriosus

Germany, Switzerland, France, Ireland, Italy
LeMaitre Vascular
Factory CRO for Medical Devices B.V.

Recruiting

Prospective and Non-randomized Registry of CardioCel 3D

Intracardiac and Septal Defects | Valve and Anulus Repair | Great Vessel Reconstruction | Peripheral Vessel Reconstruction | Suture Line Buttressing

Germany, Italy, Spain, United Kingdom
Cierra

Completed

The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

Foramen Ovale, Patent

Germany
Abbott Medical Devices

Recruiting

Trevisio Post-Approval Study (TrevisioPAS)

PFO - Patent Foramen Ovale | VSD - Muscular Ventricular Septal Defect | PIVSD - Post Infarct Muscular Ventricular Septal Defect | ASD - Atrial Septal Defect

Spain, Germany, Poland, France, Italy, Netherlands, Switzerland
Cierra

Unknown

Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism

Patent Foramen Ovale

Germany
University Hospital, Saarland

Recruiting

PFO Occlusion and Atrial Fibrillation

Patent Foramen Ovale | Atrial Fibrillation New Onset | Embolic Stroke of Undetermined Source

Germany
Cierra

Suspended

PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)

Patent Foramen Ovale

France, Germany, Belgium
Occlutech International AB

Recruiting

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion (OCCLUFLEX)

Stroke | Patent Foramen Ovale

United States, Denmark, Canada, Netherlands, Germany, United Kingdom, Finland
Abbott Medical Devices

Recruiting

AMPLATZER PFO Occluder Post Approval Study (PFO PAS)

Stroke | Patent Foramen Ovale

United States, Germany, Canada, Switzerland, Italy, Portugal, United Kingdom
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Nevoid Basal Cell Carcinoma Syndrome | Basal Cell Carcinoma | Gorlin Syndrome

Belgium, Austria, Germany, Canada
Charite University, Berlin, Germany

Recruiting

Evaluation of the Influence of Deep Brain Stimulation on the Spinal Deformities Associated With Parkinson's Disease

Parkinson Disease | Spine Degeneration | Spinal Disease | Spine Deformity

Germany
SECRETO Study Consortium
Sahlgrenska University Hospital, Sweden; Academy of Finland; Hospital District... and other collaborators

Recruiting

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO)

Ischemic Stroke | Thrombosis | Brain Infarction | Foramen Ovale, Patent

Italy, Estonia, Finland, Germany, Lithuania, Netherlands, Norway, Sweden, Turkey, United Kingdom, Greece, Portugal, Spain
Novartis Pharmaceuticals

Withdrawn

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Basal Cell Carcinoma

Greece, Switzerland, Germany, United Kingdom, Belgium, Canada, Czechia, Finland, Italy, Spain
Hoffmann-La Roche

Completed

A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

Basal Cell Carcinoma

United States, Spain, France, Germany, Netherlands, Russian Federation, Italy, Mexico, Austria, Canada
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
Sol-Gel Technologies, Ltd.

Terminated

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Basal Cell Nevus Syndrome

United States, France, Belgium, Denmark, Germany, Italy, Netherlands, Spain, United Kingdom

Clinical Trials on Nasal Septum; Deviation, Congenital in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations